Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA approves Cubist drug to treat acute skin infections
Yahoo/Reuters
Friday, June 20, 2014 - 8:05pm
tags:
FDA, Cubist Pharmaceuticals, antibiotics, Sivextro
Allergan Should Buy Perrigo For A Tax Inversion; Before Someone Else Does
Seeking Alpha
Friday, June 20, 2014 - 6:20pm
tags:
Allergan, Perrigo Company, taxes, Valeant Pharmaceuticals, M&A
AbbVie’s Shire Push Won’t Face Pfizer Hurdles in Takeover
Bloomberg
Friday, June 20, 2014 - 6:19pm
tags:
Shire, AbbVie, M&A, Pfizer
AbbVie: Is Shire Just Playing Hard to Get?
Barron's
Friday, June 20, 2014 - 6:18pm
tags:
AbbVie, Shire, M&A
AstraZeneca may sell rights to some future income to boost defenses, FT says
Yahoo/Fly on the Wall
Friday, June 20, 2014 - 2:55pm
tags:
AstraZeneca, Pfizer
Want a Big Pharma job? Apply in an emerging market--or think smaller
Fierce Pharma
Friday, June 20, 2014 - 12:33pm
tags:
hirings, layoffs
As Antibiotics Stop Working, Five Biotechs Seek Cures
24/7 Wall St
Friday, June 20, 2014 - 12:31pm
tags:
antibiotic resistance, antibiotics, Cubist Pharmaceuticals, Durata, Insmed, Medicines Company, Tetraphase Pharmaceuticals
Medtronic says was victim of cyber attack, lost patient records
Yahoo/Reuters
Friday, June 20, 2014 - 12:29pm
tags:
patients, Medtronic, cybersecurity, devices
On Sale! Drugmakers Told to Discount Orphan Drugs to Some Hospitals
WSJ Online
Friday, June 20, 2014 - 11:50am
tags:
orphan drugs
AbbVie fails to woo Shire, but investors think someone can do it
Marketwatch
Friday, June 20, 2014 - 11:22am
tags:
AbbVie, Shire, M&A
Imminent District Court Ruling Should Propel Zogenix Higher
Seeking Alpha
Friday, June 20, 2014 - 11:21am
tags:
Zogenix, Zoydro
Surging Earnings Estimates Signal Good News for Endocyte (ECYT)
Yahoo/Zacks.com
Friday, June 20, 2014 - 11:03am
tags:
earnings, Endocyte
Protalix Drug in Phase IIa Study for Gaucher Disease
Yahoo/Zacks.com
Friday, June 20, 2014 - 11:02am
tags:
Protalix BioTherapeutics, Gaucher disease, PRX-112
Merck begins tender offer to acquire Idenix
The Fly on the Wall
Friday, June 20, 2014 - 9:41am
tags:
Merck, Idenix, M&A
FDA asks for wider warning on testosterone products
Yahoo/Reuters
Friday, June 20, 2014 - 9:41am
tags:
FDA, testosterone, AbbVie, Endo Health Solutions
AbbVie - Attempt To Acquire Shire Is Driven By Opportunistic Tax Synergies
Seeking Alpha
Friday, June 20, 2014 - 9:40am
tags:
AbbVie, Shire, taxes, M&A
IPO Preview: Kite Pharma
Seeking Alpha
Friday, June 20, 2014 - 9:39am
tags:
IPOs, Kite Pharma, cancer immunotherapy
3 Key Opportunities for Medtronic and Covidien
Motley Fool
Friday, June 20, 2014 - 9:37am
tags:
Medtronic, devices, emerging markets, Covidien
AbbVie Offered $46.5 Billion for Shire as Bid Rejected
Bloomberg
Friday, June 20, 2014 - 9:36am
tags:
Shire, AbbVie, M&A
Will Allergan scramble for Shire to beat off Valeant's hostile advance?
Fierce Pharma
Thursday, June 19, 2014 - 5:47pm
tags:
Allergan, Shire, Valeant Pharmaceuticals, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.